[1983-2023 - 四十年的Helicobacter pylori - 接下来会发生什么?]
Christian Schulz1,2, Kerstin Schütte3,4, Alexander Link5
1Medizinische Klinik und Poliklinik 2, LMU - Klinikum München, München, Deutschland.
概括
四十年的Helicobacter pylori研究已经推进了其诊断和治疗,显著影响了临床实践和胃癌预防策略. 本综述强调了H. pylori管理中的关键里程碑.
科学领域:
- 胃肠病学和传染病学
背景情况:
- 四十年前发现的Helicobacter pylori标志着理解胃病的转折点.
- 从那时起,重大科学进展已经转化为临床实践.
研究的目的:
- 为了回顾过去40年的Helicobacter pylori管理的主要里程碑.
- 为突出诊断,治疗和预防与H. pylori感染相关的胃癌方面的进展.
主要方法:
- 关于H. pylori研究和临床应用的关键发展的文献综述.
- 分析诊断算法,治疗指示和治疗方案的变化.
主要成果:
- H. pylori 诊断和治疗策略的演变.
- 将H. pylori管理纳入日常临床实践.
- 专注于H. pylori在胃癌预防中的作用.
结论:
- 40年的研究已经改变了H. pylori的治疗方法.
- 持续的进步对于优化患者的治疗结果和预防癌症至关重要.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
410
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
410
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
128
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
128
Peptic Ulcer Disease IV: Management
94
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
94
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
430
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
430
Peptic Ulcer Disease I: Introduction
171
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
171
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
592
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
592


